[SYRE] QoQ Quarter Result on 31-Dec-2015 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2015
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -16.82%
YoY- -25.34%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 1,149 1,373 859 1,585 1,073 3,427 0 -
PBT -6,238 -5,430 -4,547 -3,987 -3,413 -1,427 -2,468 85.23%
Tax 0 0 0 0 0 0 0 -
NP -6,238 -5,430 -4,547 -3,987 -3,413 -1,427 -2,468 85.23%
Tax Rate - - - - - - - -
Total Cost 7,387 6,803 5,406 5,572 4,486 4,854 2,468 107.27%
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin -542.91 -395.48 -529.34 -251.55 -318.08 -41.64 0.00 -
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
EPS -11.70 -11.53 -9.95 0.00 -12.51 -5.23 -9.88 11.89%
EPS Diluted -11.70 -11.53 -9.95 0.00 -12.51 -5.23 -9.88 11.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.